Immunomodulatory role of metalloproteases in cancers: Current progress and future trends

Front Immunol. 2022 Dec 16:13:1064033. doi: 10.3389/fimmu.2022.1064033. eCollection 2022.

Abstract

Metalloproteinases (MPs) is a large family of proteinases with metal ions in their active centers. According to the different domains metalloproteinases can be divided into a variety of subtypes mainly including Matrix Metalloproteinases (MMPs), A Disintegrin and Metalloproteases (ADAMs) and ADAMs with Thrombospondin Motifs (ADAMTS). They have various functions such as protein hydrolysis, cell adhesion and remodeling of extracellular matrix. Metalloproteinases expressed in multiple types of cancers and participate in many pathological processes involving tumor genesis and development, invasion and metastasis by regulating signal transduction and tumor microenvironment. In this review, based on the current research progress, we summarized the structure of MPs, their expression and especially immunomodulatory role and mechanisms in cancers. Additionally, a relevant and timely update of recent advances and future directions were provided for the diagnosis and immunotherapy targeting MPs in cancers.

Keywords: cancers; diagnosis; immunomodulatory; metalloproteases; therapy.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Extracellular Matrix / metabolism
  • Humans
  • Matrix Metalloproteinases / metabolism
  • Neoplasms*
  • Signal Transduction
  • Thrombospondins
  • Tumor Microenvironment

Substances

  • Matrix Metalloproteinases
  • Thrombospondins